Jennifer Buell Insider Trading $AGEN AGENUS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer Buell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer Buell. Jennifer Buell is Director in Protagenic Therapeutics, Inc.\new ($PTIX) and Chief Communications Officer in AGENUS INC ($AGEN) and Chief Operating Officer in AGENUS INC ($AGEN) and COO and President in AGENUS INC ($AGEN) and President & COO in AGENUS INC ($AGEN) and VP Research & External Affairs in AGENUS INC ($AGEN).
Jennifer Buell in AGENUS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jennifer Buell: President & COO, COO and President, Chief Operating Officer, Chief Communications Officer, VP Research & External Affairs
Holdings: 116,494 shares
Current Value: $464,811
Latest Transaction: Apr 05 2021
$AGEN Market Capitalization: $345.02M
$AGEN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jennifer Buell in AGENUS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | AGEN | AGENUS INC | Buell Jennifer | President & COO | Grant | A | 2.87 | 80,838 | 232,005 | 116,494 | 35.7 K to 116.5 K (+226.72 %) |
| Dec 21 2020 | AGEN | AGENUS INC | Buell Jennifer | COO and President | Option Exercise | A | 3.70 | 900,000 | 3,330,000 | 900,000 | |
| Jun 17 2020 | AGEN | AGENUS INC | Buell Jennifer | COO and President | Option Exercise | A | 3.61 | 10,000 | 36,100 | 10,000 | |
| Dec 27 2019 | AGEN | AGENUS INC | Buell Jennifer | Chief Operating Off ... | Option Exercise | A | 4.12 | 500,000 | 2,060,000 | 500,000 | |
| Jul 25 2019 | AGEN | AGENUS INC | Buell Jennifer | Chief Operating Off ... | Option Exercise | A | 2.39 | 84,000 | 200,760 | 84,000 | |
| Jun 21 2019 | AGEN | AGENUS INC | Buell Jennifer | Chief Operating Off ... | Option Exercise | A | 2.38 | 300,000 | 714,000 | 300,000 | |
| Jun 22 2018 | AGEN | AGENUS INC | Buell Jennifer | Chief Communication ... | Option Exercise | A | 5.65 | 150,000 | 847,500 | 150,000 | |
| Dec 14 2017 | AGEN | AGENUS INC | Buell Jennifer | Chief Communication ... | Sell | S | 3.46 | 3,511 | 12,152 | 35,656 | 39.2 K to 35.7 K (-8.96 %) |
| Dec 14 2017 | AGEN | AGENUS INC | Buell Jennifer | Chief Communication ... | Grant | A | 3.59 | 10,431 | 37,447 | 39,167 | 28.7 K to 39.2 K (+36.30 %) |
| Sep 06 2017 | AGEN | AGENUS INC | Buell Jennifer | VP Research & Exter ... | Grant | A | 3.72 | 4,375 | 16,275 | 28,736 | 24.4 K to 28.7 K (+17.96 %) |
Page: 1